ESC Professional Premium Access

Impact of diabetes and glucose-lowering therapy on post-operative atrial fibrillation after cardiac surgery: secondary analysis of the SEARCH-AF CardioLink-1 randomized clinical trial

Congress Presentation

About the speaker

Mr Arjun Pandey

McMaster University, Hamilton (Canada)
0 follower

7 more presentations in this session

Prognosis of low-flow low-gradient aortic valve stenosis with atrial fibrillation

Speaker: Doctor R. Nishinarita (Nerima, JP)


Sodium-glucose cotransporter 2 inhibitors not only suppress recurrence after atrial fibrillation ablation but also cause atrial reverse remodeling

Speaker: Associate Professor T. Mine (Nishinomiya, JP)


Development of the new risk score to predict occurrence of atrial fibrillation early after acute myocardial infarction.

Speaker: Doctor K. Iwakura (Osaka, JP)


Prognosis of atrial fibrillation with or without comorbidities. Analysis of younger adults from a nationwide database

Speaker: Professor L. Fauchier (Tours, FR)


Influence of obesity and overweight on the association between sleep-disordered breathing and atrial fibrillation: the DASAP-HF study

Speaker: Professor G. Boriani (Modena, IT)


Access the full session

Atrial fibrillation in context of concomitant medical conditions

Speakers: Mr A. Pandey, Doctor R. Nishinarita, Associate Professor T. Mine, Doctor K. Iwakura, Professor L. Fauchier...

About the event


ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb